Thoratec Corporation HeartMate PHP™ Cardiogenic Shock Trial

计划入组 9 人 · 首次发布于 2014 年 10 月 31 日

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)

计划入组 2,000 人 · 首次发布于 2026 年 1 月 8 日

Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy

计划入组 24 人 · 首次发布于 2008 年 9 月 19 日

Glycopyranosyl lipid adjuvant (Revelation Biosciences)

Sabin mOPV2(Fidec Corporation)

MKCC1106-MT(Mannkind Corporation)

Venn Biosciences Corporation

United States

Ambit Biosciences Corporation

United States

AURA BIOSCIENCES

India

Elephas Biosciences Expands Personalized Oncology to India Through Exclusive Partnership with Neuberg Diagnostics

Elephas Biosciences Secures $40M Series B-2 Funding to Launch Live Tumor Profiling Platform for Immunotherapy Response Prediction

Elephas Biosciences and Mithrl Combine Real-Time Tumor Profiling with AI to Advance Immunotherapy Response Prediction